TempraMed Technologies Ltd. (CSE:VIVI)
0.5200
-0.1000 (-16.13%)
At close: Jun 2, 2026
TempraMed Technologies Company Description
TempraMed Technologies Ltd., a medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products.
Its primary focus is storage and management of injectable for temperature-sensitive medications. The company provides VIVI Cap, an insulin insulation and travel case; VIVI Cap Smart, a connected insulin storage and protection; VIVI Med, a temperature medication; and VIVI Epi, a Storage and Protection for EpiPen.
The company was founded in 2014 and is based in Burnaby, Canada.
TempraMed Technologies Ltd.
| Country | Canada |
| Founded | 2014 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| CEO | Ron Nagar |
Contact Details
Address: 501-3292 Burnaby, BC BC Canada | |
| Website | tempramed.com |
Stock Details
| Ticker Symbol | VIVI |
| Exchange | Canadian Securities Exchange |
| Stock Type | Common Stock |
| Reporting Currency | CAD |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Ron Nagar | Chief Executive Officer |
| Gabriel Kabazo | Chief Financial Officer |
| Elina Nagar | Chief Operating Officer |